{"id":"https://openalex.org/W19414593","doi":"https://doi.org/10.1176/ajp.152.5.673","title":"Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships","display_name":"Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships","publication_year":1995,"publication_date":"1995-05-01","ids":{"openalex":"https://openalex.org/W19414593","doi":"https://doi.org/10.1176/ajp.152.5.673","mag":"19414593","pmid":"https://pubmed.ncbi.nlm.nih.gov/7726306"},"language":"en","primary_location":{"id":"doi:10.1176/ajp.152.5.673","doi":"https://doi.org/10.1176/ajp.152.5.673","is_oa":false,"landing_page_url":"https://doi.org/10.1176/ajp.152.5.673","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109977230","display_name":"MATIG R. MAVISSAKALIAN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M R Mavissakalian","raw_affiliation_strings":["Department of Psychiatry, Ohio State University College of Medicine, Columbus, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Ohio State University College of Medicine, Columbus, USA","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113639668","display_name":"James M. Perel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J M Perel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":8.9713,"has_fulltext":false,"cited_by_count":69,"citation_normalized_percentile":{"value":0.97761605,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"152","issue":"5","first_page":"673","last_page":"682"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11083","display_name":"Cardiac Health and Mental Health","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imipramine","display_name":"imipramine","score":1.0},{"id":"https://openalex.org/keywords/panic-disorder-with-agoraphobia","display_name":"panic disorder with agoraphobia","score":0.968999981880188},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.9610000252723694},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.7639999985694885},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.800000011920929},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.5720000267028809},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7749999761581421}],"concepts":[{"id":"https://openalex.org/C2778678127","wikidata":"https://www.wikidata.org/wiki/Q174589","display_name":"Agoraphobia","level":4,"score":0.8618951439857483},{"id":"https://openalex.org/C2776312127","wikidata":"https://www.wikidata.org/wiki/Q5299247","display_name":"Dose-ranging study","level":5,"score":0.7553932070732117},{"id":"https://openalex.org/C2779145073","wikidata":"https://www.wikidata.org/wiki/Q58396","display_name":"Imipramine","level":3,"score":0.7454050779342651},{"id":"https://openalex.org/C2780712732","wikidata":"https://www.wikidata.org/wiki/Q208450","display_name":"Panic","level":3,"score":0.6369717121124268},{"id":"https://openalex.org/C2777529043","wikidata":"https://www.wikidata.org/wiki/Q741713","display_name":"Panic disorder","level":3,"score":0.5686429738998413},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4834471642971039},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.39957115054130554},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3621627688407898},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.34412890672683716},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.33722740411758423},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.12249243259429932},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000379","descriptor_name":"Agoraphobia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000379","descriptor_name":"Agoraphobia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D000379","descriptor_name":"Agoraphobia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000553","descriptor_name":"Ambulatory Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010555","descriptor_name":"Personality Inventory","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016015","descriptor_name":"Logistic Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016584","descriptor_name":"Panic Disorder","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016584","descriptor_name":"Panic Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D016584","descriptor_name":"Panic Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1176/ajp.152.5.673","doi":"https://doi.org/10.1176/ajp.152.5.673","is_oa":false,"landing_page_url":"https://doi.org/10.1176/ajp.152.5.673","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:7726306","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7726306","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of psychiatry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6800000071525574}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G2193352360","display_name":null,"funder_award_id":"MH42730","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G2584013122","display_name":"ANTIDEPRESSANTS IN THE TREATMENT OF ANXIETY DISORDERS","funder_award_id":"5r01mh042730-13","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W186271800","https://openalex.org/W1515756878","https://openalex.org/W1963895082","https://openalex.org/W1975895811","https://openalex.org/W1981818274","https://openalex.org/W1986277865","https://openalex.org/W1996146322","https://openalex.org/W2003582687","https://openalex.org/W2004948294","https://openalex.org/W2015064730","https://openalex.org/W2016505524","https://openalex.org/W2016847652","https://openalex.org/W2019194252","https://openalex.org/W2029476305","https://openalex.org/W2037061841","https://openalex.org/W2041753766","https://openalex.org/W2043296434","https://openalex.org/W2047149397","https://openalex.org/W2051224229","https://openalex.org/W2057304728","https://openalex.org/W2071703232","https://openalex.org/W2077228555","https://openalex.org/W2090502427","https://openalex.org/W2093943179","https://openalex.org/W2101949700","https://openalex.org/W2103990085","https://openalex.org/W2162161566","https://openalex.org/W2399926710","https://openalex.org/W2400847578","https://openalex.org/W2414830097","https://openalex.org/W2417758972","https://openalex.org/W2475203945","https://openalex.org/W2801356077"],"related_works":["https://openalex.org/W2077228555","https://openalex.org/W2417758972","https://openalex.org/W2410658664","https://openalex.org/W186271800","https://openalex.org/W2006313794","https://openalex.org/W1978230560","https://openalex.org/W2400764215","https://openalex.org/W2016847652","https://openalex.org/W2403576812","https://openalex.org/W2083683301"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1,221],"aim":[2],"of":[3,12,17,55,75,83,105,187,200],"this":[4,234],"study":[5],"was":[6,135,138,183],"to":[7,23,48,51,90,93,108],"characterize":[8],"the":[9,15,118,128,132,149,155,164,170,177,185,198,252],"specific":[10],"effects":[11,111,232],"imipramine":[13,76,227],"in":[14,117,184,233],"treatment":[16,91],"panic":[18,35,84],"disorder":[19,36],"with":[20,34,37,131,143,204,212,236],"agoraphobia":[21,38],"and":[22,26,77,80,85,88,100,115,121,151,166,172,208,242,246,255],"delineate":[24],"dose-response":[25,141],"possibly":[27],"plasma":[28,181,206,244],"level-response":[29],"relationships.":[30],"METHOD:":[31],"Eighty":[32],"patients":[33,126],"were":[39,96,112,159],"randomly":[40],"assigned,":[41],"for":[42,239],"an":[43],"8-week,":[44],"double-blind":[45],"dose-ranging":[46],"trial,":[47],"placebo":[49,156,165],"or":[50,67,169],"a":[52,139,193],"weight-adjusted":[53],"dose":[54],"imipramine:":[56],"(low)":[57],"0.5":[58],"mg/kg":[59,64,70],"per":[60,65,71],"day,":[61,66],"(medium)":[62],"1.5":[63],"(high)":[68],"3.0":[69],"day.":[72],"Plasma":[73],"levels":[74,191,207,216],"N-methylimipramine,":[78],"patients'":[79],"clinicians'":[81],"ratings":[82],"phobic":[86],"symptoms,":[87],"response":[89,201],"according":[92],"operationalized":[94],"criteria":[95],"ascertained":[97],"after":[98],"4":[99],"8":[101],"weeks.":[102],"RESULTS:":[103],"Rates":[104],"dropouts":[106],"due":[107],"drug":[109,133,180],"side":[110],"6%,":[113],"15%,":[114],"36%":[116],"low-,":[119],"medium-,":[120],"high-dose":[122,173],"groups,":[123],"respectively;":[124],"63":[125],"completed":[127],"study.":[129],"Compliance":[130],"regimen":[134],"high.":[136],"There":[137,158],"positive":[140],"relationship,":[142],"significant":[144,161,231],"group":[145],"differences":[146,162],"involving":[147],"primarily":[148],"high-":[150],"medium-dose":[152],"groups":[153,168],"versus":[154],"group.":[157],"no":[160,213],"between":[163],"low-dose":[167],"medium-":[171],"groups.":[174],"For":[175,196],"phobias,":[176],"best":[178],"total":[179],"level":[182],"range":[186],"110-140":[188],"ng/ml;":[189],"higher":[190],"had":[192],"detrimental":[194],"effect.":[195],"panic,":[197],"probability":[199],"increased":[202],"quickly":[203],"greater":[205],"then":[209],"tapered":[210],"off,":[211],"improvement":[214],"at":[215],"beyond":[217],"140":[218],"ng/ml.":[219],"CONCLUSIONS:":[220],"results":[222],"provide":[223],"strong":[224],"evidence":[225],"that":[226,248],"has":[228],"specific,":[229],"clinically":[230],"disorder,":[235],"practical":[237],"implications":[238],"target":[240],"doses":[241],"optimal":[243],"concentrations,":[245],"suggest":[247],"different":[249],"mechanisms":[250],"underlie":[251],"drug's":[253],"antipanic":[254],"antiphobic":[256],"effects.":[257]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}